[1]
I. Khammas, Ali Abdulhussain Kasim, and Bassam Francis, “Serum Levels of Advanced Oxidation Protein Products and some Liver Function Markers in Chronic Myeloid Leukemia-Chronic Phase Patients Receiving Imatinib or Nilotinib”, Iraqi Journal of Pharmaceutical Sciences , vol. 34, no. 2, pp. 40–46, Jun. 2025, doi: 10.31351/vol34iss2pp40-46.